Procept biorobotics stock.

Discover PROCEPT BioRobotics' earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers. ... Independent Director exercised options and sold US$663k worth of stock Jun 24. BioRobotics Corporation Announces Additional Positive Coverage Policies Regarding …Key Insights. Significantly high institutional ownership implies PROCEPT BioRobotics' stock price is sensitive to their trading actions. The top 7 shareholders own 51% of the companyView PROCEPT BioRobotics Corporation PRCT investment & stock information. Get the latest PROCEPT BioRobotics Corporation PRCT detailed stock …The most recent slide in PROCEPT BioRobotics stock may reflect the dawning recognition from other investors that perhaps the share price is a bit too rich. After all, the company’s immediate market is less than $1 billion, according to our math.

Get the latest Procept Biorobotics Corp (PRCT) stock quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. See the company's financials, income statement, balance sheet, cash flow, and more on Google Finance.

Feb 28, 2023 · REDWOOD CITY, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by ... PROCEPT BioRobotics’ stock opened at a price of $33.27 on Friday. The company boasts a current ratio of 6.40 and a quick ratio of 5.21 while maintaining a debt-to-equity ratio of 0.34. Notably, the company’s fifty-day simple moving average stands at $33.35 with a 200-day simple moving average at $33.23.

PROCEPT BioRobotics to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 28, 2023REDWOOD CITY, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation ...PROCEPT BioRobotics Corporation: RECONCILIATION OF GAAP NET LOSS TO ADJUSTED EBITDA (Unaudited, in thousands) Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Net loss $ (25,285) $ (19,184) $ (53,771) $ (36,369) Depreciation and amortization expense 642 717 1,435 1,475 Stock-based compensation expense 5,104 2,676 8,827 ...Nov 30, 2023 · PROCEPT BioRobotics has a beta of 0.63, indicating that its stock price is 37% less volatile than the S&P 500. Comparatively, Alphatec has a beta of 1.35, indicating that its stock price is 35% more volatile than the S&P 500. Thursday, April 27, 2023 - Procept Biorobotics Corp ( PRCT) reported downside earnings and upside revenues. Procept Biorobotics Corp's earnings came in at an EPS loss of $0.63 per share, 9% lower than estimates for an EPS loss of $0.58 per share. The firm's loss per share expanded by 62% since reporting a loss of $0.39 per share a year ago.

Dec 2, 2023 · Procept BioRobotics Corp (PRCT) registered a 0.78% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 0.78% in intraday trading to $37.36 this Friday, 12/01/23, hitting a weekly high. The stock’s 5-day price performance is 5.69%, and it has moved by 35.61% in 30 days.

PROCEPT BioRobotics’ stock opened at a price of $33.27 on Friday. The company boasts a current ratio of 6.40 and a quick ratio of 5.21 while maintaining a debt-to-equity ratio of 0.34. Notably, the company’s fifty-day simple moving average stands at $33.35 with a 200-day simple moving average at $33.23.

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus …The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.Procept Biorobotics reels in $85M to make a splash with water-based robotic system for prostate surgery By Andrea Park Jun 30, 2021 10:00am Aquablation benign prostatic hyperplasia medical device ...PROCEPT BioRobotics last announced its quarterly earnings results on November 1st, 2023. The reported ($0.51) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.53) by $0.02. The company had revenue of $35.10 million for the quarter, compared to the consensus estimate of $33.44 million.According to 4 analyst offering 12-month price targets in the last 3 months, PROCEPT BioRobotics has an average price target of $49.75 with a high of $58.00 and a low of $44.00. Below is a summary ...PROCEPT BioRobotics reports unaudited financial results for Q3 2023, with total revenue of $35.1 million, a 72% increase YoY. U.S. handpiece and consumables revenue reached $17.0 million, up 113% YoY. Monthly account utilization increased by 5% compared to Q2 2023. The company sold 38 U.S. robotic systems, with robotic system …

PROCEPT BioRobotics Corporation appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead ...CharlieAJA/iStock via Getty Images. Procept BioRobotics ( NASDAQ: PRCT) is down 19% in early Thursday afternoon trading after its Q1 2023 financial results missed on the bottom line. The medical ...In addition, PROCEPT BioRobotics has granted the underwriters a 30-day option to purchase up to an additional 663,325 shares of its common stock at the public offering price, less underwriting ...With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.PROCEPT BioRobotics Stock Up 2.9 %. PRCT stock opened at $34.70 on Friday. The company has a quick ratio of 7.89, a current ratio of 8.91 and a debt-to-equity ratio of 0.18. PROCEPT BioRobotics Co ...

4 ส.ค. 2566 ... Shearman & Sterling advised the underwriters of PROCEPT BioRobotics Corporation's follow-on offering of 5085494 shares of common stock at a ...PROCEPT BioRobotics, a surgical robotics company developing intelligent solutions to transform the field of urology, has included HydroCision technology as part of Aquablation therapy ®, the ...

Nov 29, 2023 · B. Riley Lowers PROCEPT BioRobotics' PT to $55 From $60 on Lower Multiple, Keeps Buy Rating. Nov. 02. MT. Transcript : PROCEPT BioRobotics Corporation, Q3 2023 Earnings Call, Nov 01, 2023. Nov. 01. CI. Earnings Flash (PRCT) PROCEPT BIOROBOTICS Posts Q3 Revenue $35.1M, vs. Street Est of $33.4M. Nov. 01. Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Procept wrote in a revised S-1 filing with the U.S. Securities and Exchange Commission that it intends to offer 5.5M shares of its stock at an expected $22-$24/range. The company is also granting ...NVIDIA Corporation Common Stock. $416.10 +5.93 +1.45%. O. Realty Income Corporation Common Stock. $51.56 -0.50 -0.96%. PROCEPT BioRobotics Corporation Common Stock (PRCT) Pre-Market Stock Quotes ... 5 พ.ย. 2563 ... At PROCEPT BioRobotics, we are developing game changing surgical options for men in the treatment of BPH. Interested in being a part of the ...Oct 25, 2023 · PROCEPT BioRobotics Corporation appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead ... The fluctuation in the stock market for PROCEPT BioRobotics coincides with abrdn plc’s strategic decision to increase its holdings. Despite opening at $36.10 on Tuesday, PRCT stock has experienced significant volatility over the last twelve months, ranging from a low of $25.29 to a high of $52.40. It is evident that market conditions have …B. Riley Raises PROCEPT BioRobotics' Price Target to $60 From $53, Keeps Buy Rating Nov. 04: MT BTIG Starts PROCEPT BioRobotics at Neutral 2022: MT Truist Securities Starts PROCEPT BioRobotics at Buy With $58 Price Target 2022: MTREDWOOD CITY, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- PROCEPT ® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended March 31, 2023.. Recent …

Procept Biorobotics reels in $85M to make a splash with water-based robotic system for prostate surgery By Andrea Park Jun 30, 2021 10:00am Aquablation benign prostatic hyperplasia medical device ...

REDWOOD CITY, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by ...

The mean of analysts' price targets for PROCEPT BioRobotics Corporation (PRCT) points to a 25.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.Nov 30, 2023 · The stock of Procept BioRobotics Corp (PRCT) has gone up by 9.73% for the week, with a 48.65% rise in the past month and a 9.92% rise in the past quarter. The volatility ratio for the week is 4.42%, and the volatility levels for the past 30 days are 5.89% for PRCT. The simple moving […] Procept Biorobotics Corp’s ( PRCT) price is currently down 24.19% so far this month. During the month of March, Procept Biorobotics Corp’s stock price has reached a high of $38.07 and a low of $28.28. Over the last year, Procept Biorobotics Corp has hit prices as high as $52.40 and as low as $28.30. Year to date, Procept …PROCEPT BioRobotics Corporation appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead ...Oct 25, 2023 · PROCEPT BioRobotics Corporation appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead ... SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended September 30, 2023. Recent …The most recent slide in PROCEPT BioRobotics stock may reflect the dawning recognition from other investors that perhaps the share price is a bit too rich. After all, the company’s immediate market is less than $1 billion, according to our math.About PROCEPT BioRobotics Stock. PROCEPT BioRobotics is a clinical-stage medical device company based in Silicon Valley. The Company has developed a disruptive surgical product for transurethral resection of prostate tissue – The AquaBeam® – and other treatment and diagnostic applications. The AquaBeam is a personalized image-guided tissue ...Find real-time PRCT - PROCEPT BioRobotics Corp stock quotes, company profile, news and forecasts from CNN Business. ... PROCEPT BioRobotics Corp (NASDAQ:PRCT) 36.97. Delayed Data. As of Nov 29According to 5 analyst offering 12-month price targets in the last 3 months, PROCEPT BioRobotics has an average price target of $48.4 with a high of $55.00 and a low of $43.00.PROCEPT BioRobotics Corporation is a surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with …14 ธ.ค. 2565 ... PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics ... Stock Quotes. Get quotes for stocks: To display multiple quotes,enter ...

Open a brokerage account and deposit funds in it to purchase stock in a company, explains the Wall Street Journal. Companies such as Charles Schwab, E-Trade, and Ameritrade provide brokerage services.Oct 25, 2023 · Procept Biorobotics Corp Stock Price History. Procept Biorobotics Corp’s price is currently down 20.09% so far this month. During the month of October, Procept Biorobotics Corp’s stock price has reached a high of $33.00 and a low of $26.13. Over the last year, Procept Biorobotics Corp has hit prices as high as $47.75 and as low as $25.29 ... Inside Procept Biorobotics Corp's 10-K Annual Report: ... compliance with the rules and regulations of the SEC and those of any stock exchange on which our securities are traded, investor relations, and other administrative and professional services expenses, though it may fluctuate from quarter to quarter. ...Procept wrote in a revised S-1 filing with the U.S. Securities and Exchange Commission that it intends to offer 5.5M shares of its stock at an expected $22-$24/range. The company is also granting ...Instagram:https://instagram. builder stocksbarrons subscription dealsblack vchow much is a pure silver dollar worth PROCEPT BioRobotics Corporation: RECONCILIATION OF GAAP NET LOSS TO ADJUSTED EBITDA (Unaudited, in thousands) Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Net loss $ (25,285) $ (19,184) $ (53,771) $ (36,369) Depreciation and amortization expense 642 717 1,435 1,475 Stock-based compensation expense 5,104 2,676 8,827 ...PROCEPT BioRobotics last announced its quarterly earnings results on November 1st, 2023. The reported ($0.51) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.53) by $0.02. The company had revenue of $35.10 million for the quarter, compared to the consensus estimate of $33.44 million. is amazon stock a good buybest water etfs SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing ... future buy PROCEPT BioRobotics Corporation appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead ...This Registration Statement on Form S-1 (this "Registration Statement") is being filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended, for the sole purpose of increasing the aggregate number of shares of common stock offered by PROCEPT BioRobotics Corporation (the “Registrant”) by 1,214,400 shares, 158,400 of which are …SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended September 30, 2023.